Translocator protein distribution volume predicts reduction of symptoms during open-label trial of celecoxib in major depressive disorder
S Attwells, E Setiawan, PM Rusjan, C Xu, C Hutton… - Biological …, 2020 - Elsevier
… study reported a negative result within a sample combining 5 … optimal window of PFC TSPO
V T and ACC TSPO V T , and a univariate analysis of variance was performed to determine a …
V T and ACC TSPO V T , and a univariate analysis of variance was performed to determine a …
Comparison of the efficacy and safety of CELBESTA® versus CELEBREX® in patients with rheumatoid arthritis: a 6-week, multicenter, double-blind, double-dummy …
HS Kim, WH Choi, BY Kim, SS Kim… - Journal of …, 2020 - journals.sagepub.com
… In this study, CELBESTA® and CELEBREX® treatment resulted in rapid reduction of pain
in RA patients as assessed by the 100-mm VAS score and DAS28-ESR score. In RA patients, …
in RA patients as assessed by the 100-mm VAS score and DAS28-ESR score. In RA patients, …
Optimal biological dose: a systematic review in cancer phase I clinical trials
J Fraisse, D Dinart, D Tosi, C Bellera, C Mollevi - BMC cancer, 2021 - Springer
… Few articles combining immunotherapy with biological agents and clearly mentioning the
OBD have been identified (n = 3). For those particular cases, OBD was assessed using …
OBD have been identified (n = 3). For those particular cases, OBD was assessed using …
Insight into the colonic disposition of celecoxib in humans
G Lemmens, J Brouwers, J Snoeys, P Augustijns… - European Journal of …, 2020 - Elsevier
… assess the optimal time and colonic region to sample tissue for the evaluation of the disposition
of celecoxib, we determined… reflects the low solubility of the compound in combination …
of celecoxib, we determined… reflects the low solubility of the compound in combination …
Integration analysis of metabolites and single nucleotide polymorphisms improves the prediction of drug response of celecoxib
X Xing, P Ma, Q Huang, X Qi, B Zou, J Wei, L Tao, L Li… - Metabolomics, 2020 - Springer
… In this study, we attempted to combine metabolic biomarkers … to optimal the prediction of
celecoxib pharmacokinetics. Our … better reflects biological phenotype, we only combined genetic …
celecoxib pharmacokinetics. Our … better reflects biological phenotype, we only combined genetic …
… as an adjunct to treatment-as-usual in children and youth with obsessive–compulsive disorder: protocol for a single-site randomised quadruple-blind phase II study
… study involving biosample collection for correlative biology; … per day (2–5 mg/kg per dose);
those >25 kg will receive 100 … paediatric dosing in children (maximum 4 mg/kg per dose). The …
those >25 kg will receive 100 … paediatric dosing in children (maximum 4 mg/kg per dose). The …
[HTML][HTML] Comparison of the benefits of celecoxib combined with anticancer therapy in advanced non-small cell lung cancer: A meta-analysis
… A phase I trial to determine the optimal biological dose of celecoxib when combined with
erlotinib in advanced non-small cell lung cancer. Clinical cancer research: an official journal of …
erlotinib in advanced non-small cell lung cancer. Clinical cancer research: an official journal of …
Effects of Resveratrol Co-Administration on Celecoxib Disposition and Pharmacokinetics in Healthy Volunteers
… There was no significant change in the time it takes for celecoxib to reach the maximum …
dose of celecoxib and consequently lessen its side effects. RSV and celecoxib combination …
dose of celecoxib and consequently lessen its side effects. RSV and celecoxib combination …
Celecoxib and Afatinib synergistic enhance radiotherapy sensitivity on human non-small cell lung cancer A549 cells
P Zhang, E Song, M Jiang, Y Song - … Journal of Radiation Biology, 2021 - Taylor & Francis
… Our current study is designed to address the possibility that the combination of Celecoxib …
Citation2014), however, to the best of our knowledge, this is the first report testing the effect of …
Citation2014), however, to the best of our knowledge, this is the first report testing the effect of …
Celecoxib as a valuable adjuvant in cutaneous melanoma treated with trametinib
… the dabrafenib and trametinib combination, extending the tumor … However, the optimal dose
should be selected carefully as … melanoma biology and celecoxib’s capabilities are needed. …
should be selected carefully as … melanoma biology and celecoxib’s capabilities are needed. …